These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29908344)

  • 21. Redox nanoparticle therapeutics to cancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect.
    Yoshitomi T; Ozaki Y; Thangavel S; Nagasaki Y
    J Control Release; 2013 Nov; 172(1):137-143. PubMed ID: 23958903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries.
    Yoshitomi T; Nagasaki Y
    Adv Healthc Mater; 2014 Aug; 3(8):1149-61. PubMed ID: 24482427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of VEGFR1
    Meng D; Meng M; Luo A; Jing X; Wang G; Huang S; Luo M; Shao S; Zhao X; Liu R
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):411-427. PubMed ID: 30483898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
    Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
    J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
    Maiti A; Takabe K; Hait NC
    Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
    Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
    Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cold atmospheric plasma conveys selectivity on triple negative breast cancer cells both in vitro and in vivo.
    Xiang L; Xu X; Zhang S; Cai D; Dai X
    Free Radic Biol Med; 2018 Aug; 124():205-213. PubMed ID: 29870749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alcohol promotes migration and invasion of triple-negative breast cancer cells through activation of p38 MAPK and JNK.
    Zhao M; Howard EW; Parris AB; Guo Z; Zhao Q; Yang X
    Mol Carcinog; 2017 Mar; 56(3):849-862. PubMed ID: 27533114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.
    Guo GC; Wang JX; Han ML; Zhang LP; Li L
    Cell Oncol (Dordr); 2017 Apr; 40(2):157-166. PubMed ID: 28054302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inverse agonist of estrogen-related receptor α suppresses the growth of triple negative breast cancer cells through ROS generation and interaction with multiple cell signaling pathways.
    Wu YM; Chen ZJ; Jiang GM; Zhang KS; Liu Q; Liang SW; Zhou Y; Huang HB; Du J; Wang HS
    Oncotarget; 2016 Mar; 7(11):12568-81. PubMed ID: 26871469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
    Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
    Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
    Tilli TM; Carels N; Tuszynski JA; Pasdar M
    Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photodynamic treatment with anionic nanoclays containing curcumin on human triple-negative breast cancer cells: Cellular and biochemical studies.
    Khorsandi K; Hosseinzadeh R; Shahidi FK
    J Cell Biochem; 2019 Apr; 120(4):4998-5009. PubMed ID: 30302810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel compound LingH2-10 inhibits the growth of triple negative breast cancer cells in vitro and in vivo as a selective inverse agonist of estrogen-related receptor α.
    Ning Y; Chen H; Du Y; Ling H; Zhang L; Chen L; Qi H; Shi X; Li Q
    Biomed Pharmacother; 2017 Sep; 93():913-922. PubMed ID: 28715872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines.
    Andreidesz K; Szabo A; Kovacs D; Koszegi B; Bagone Vantus V; Vamos E; Isbera M; Kalai T; Bognar Z; Kovacs K; Gallyas F
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
    Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
    Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.
    Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L
    Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080
    [No Abstract]   [Full Text] [Related]  

  • 39. Emodin inhibits epithelial‑mesenchymal transition and metastasis of triple negative breast cancer via antagonism of CC‑chemokine ligand 5 secreted from adipocytes.
    Song X; Zhou X; Qin Y; Yang J; Wang Y; Sun Z; Yu K; Zhang S; Liu S
    Int J Mol Med; 2018 Jul; 42(1):579-588. PubMed ID: 29693154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
    Sharma P; Kumar S
    Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.